South Korea
· Delayed Price · Currency is KRW REYON Pharmaceutical Statistics
Total Valuation
KRX:102460 has a market cap or net worth of KRW 220.46 billion. The enterprise value is 426.16 billion.
| Market Cap | 220.46B |
| Enterprise Value | 426.16B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:102460 has 18.34 million shares outstanding. The number of shares has increased by 0.79% in one year.
| Current Share Class | 18.34M |
| Shares Outstanding | 18.34M |
| Shares Change (YoY) | +0.79% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 81.15% |
| Owned by Institutions (%) | 3.16% |
| Float | 2.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.48 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -29.91 |
| EV / Sales | 2.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -45.09 |
Financial Position
The company has a current ratio of 0.60, with a Debt / Equity ratio of 0.92.
| Current Ratio | 0.60 |
| Quick Ratio | 0.34 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | 181.50 |
| Debt / FCF | -22.67 |
| Interest Coverage | -2.37 |
Financial Efficiency
Return on equity (ROE) is -5.93% and return on invested capital (ROIC) is -3.82%.
| Return on Equity (ROE) | -5.93% |
| Return on Assets (ROA) | -3.35% |
| Return on Invested Capital (ROIC) | -3.82% |
| Return on Capital Employed (ROCE) | -7.68% |
| Revenue Per Employee | 339.42M |
| Profits Per Employee | -32.38M |
| Employee Count | 440 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 2.79 |
Taxes
In the past 12 months, KRX:102460 has paid 2.09 billion in taxes.
| Income Tax | 2.09B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.54% in the last 52 weeks. The beta is 0.54, so KRX:102460's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -6.54% |
| 50-Day Moving Average | 11,202.60 |
| 200-Day Moving Average | 11,409.85 |
| Relative Strength Index (RSI) | 60.35 |
| Average Volume (20 Days) | 81,937 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:102460 had revenue of KRW 149.34 billion and -14.25 billion in losses. Loss per share was -774.17.
| Revenue | 149.34B |
| Gross Profit | 46.79B |
| Operating Income | -25.91B |
| Pretax Income | -12.16B |
| Net Income | -14.25B |
| EBITDA | 1.18B |
| EBIT | -25.91B |
| Loss Per Share | -774.17 |
Balance Sheet
The company has 8.56 billion in cash and 214.26 billion in debt, giving a net cash position of -205.70 billion or -11,215.33 per share.
| Cash & Cash Equivalents | 8.56B |
| Total Debt | 214.26B |
| Net Cash | -205.70B |
| Net Cash Per Share | -11,215.33 |
| Equity (Book Value) | 233.12B |
| Book Value Per Share | 12,734.92 |
| Working Capital | -53.78B |
Cash Flow
In the last 12 months, operating cash flow was -5.30 billion and capital expenditures -4.15 billion, giving a free cash flow of -9.45 billion.
| Operating Cash Flow | -5.30B |
| Capital Expenditures | -4.15B |
| Free Cash Flow | -9.45B |
| FCF Per Share | -515.36 |
Margins
Gross margin is 31.33%, with operating and profit margins of -17.35% and -9.54%.
| Gross Margin | 31.33% |
| Operating Margin | -17.35% |
| Pretax Margin | -8.14% |
| Profit Margin | -9.54% |
| EBITDA Margin | 0.79% |
| EBIT Margin | -17.35% |
| FCF Margin | n/a |
Dividends & Yields
KRX:102460 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.79% |
| Shareholder Yield | -0.79% |
| Earnings Yield | -6.46% |
| FCF Yield | -4.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 29, 2020 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
KRX:102460 has an Altman Z-Score of 1.13 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.13 |
| Piotroski F-Score | 3 |